Articles

By Mark Land, M.S., RAC-US, AAHP President The Homeopathic Pharmacopoeia of the United States (HPUS) is the legal basis for marketing homeopathic drug products in the United States and many…

From its earliest roots in 19th century pharmacopeias to its modern digital format, the Homoeopathic Pharmacopeia of the United States (HPUS) has evolved alongside the regulatory landscape. This newly added…

An Interview with Eric L. Foxman, Pharm. (Ret.) Beyond monographing more than 1,300 substances, the Homeopathic Pharmacopeia of the United States (HPUS) offers other vital information specific to procuring, producing,…

The Homoeopathic Pharmacopeia of the United States (HPUS) has been in continuous publication since 1897, when it was first published by the Committee on Pharmacy of the American Institute of…

Reprinted from AAHP NetworkNews November 1998 The following are excerpts of the remarks made in 1998 by Ed Miracco (US FDA) to AAHP members and guests at the association’s 75th…

By Mark Land, M.S., RAC-US, AAHP President The turbulent nature of the legal and regulatory environment in general over the past several years and, more pointedly, with the arrival of…

As states across the U.S. continue to implement Extended Producer Responsibility (EPR) laws for packaging, homeopathic product manufacturers must stay informed about compliance requirements. While pharmaceutical packaging is often (but…

Given the importance that natural shoppers and natural product retailers place on certifications that ensure pure ingredients, ethically produced products, and protection of the environment, investing in key certifications may…

By Mark Land, M.S., RAC-US, AAHP President As we settle into 2025, opportunities should increase for natural products, including homeopathy, from a more favorable climate within government.   From Capitol…